Syngenta AG (SYT) - NYSE
  • Thu, May 19, 11:48 AM
    • A Monsanto (MON +4.9%) takeover by Bayer is considered "relatively unlikely" by Jefferies analyst Laurence Alexander, as he expects MON to object to the offer given its conviction in its R&D pipeline and longer-term competitive advantages.
    • Alexander thinks shares of Syngenta (SYT -0.5%) and DuPont (DD -0.7%) could be pressured as regulatory scrutiny likely would intensify if MON gets acquired, and BASF (OTCQX:BASFY -1.4%) could fall on investor concerns of a potential counter-bid.
    • But the analyst sees a potential MON takeover as positive for shares of Novozymes (OTCPK:NVZMY -0.1%) and FMC Corp. (FMC -0.7%), as "a further roll-up of 'specialty generic' agrichemical assets could entice capital, and FMC would be a plausible anchor for such an attempt."
    • Jefferies rates MON as a Hold with a $95 price target.
    • Now read Bayer investor "deeply concerned" about move for Monsanto
    | Thu, May 19, 11:48 AM | 8 Comments
  • Thu, May 12, 3:37 PM
    • Monsanto (MON +8.5%) remains sharply higher though off highs of the day, following headlines that Bayer (OTCPK:BAYRY -4.1%) and BASF (OTCQX:BASFY -1.7%) are considering a possible acquisition of the company.
    • Financial Times reports that MON is interested in forming some sort of combination with the agrochemical businesses of either of the two companies but opposes any deal that would turn it into a division of a German company.
    • Piper Jaffray analysts say the interest in acquiring MON is mere speculation, seeing a potential joint venture as a more likely outcome as "we believe Monsanto remains committed to building a chemistry business."
    • J.P. Morgan believes Bayer would need to raise equity given the size of the deal, and thinks Bayer investors likely would be only lukewarm around the potential deal given limited accretion and investor desire for Bayer to strength its pharma pipeline following recent setbacks.
    • Analysts say a MON takeover likely would draw intense scrutiny from global regulators already confronting an unprecedented wave of consolidation in the crop chemicals industry involving the likes of Dow Chemical (DOW +0.8%), DuPont (DD +0.2%) and Syngenta (SYT +0.4%).
    • Now read Seed war sparked: Bayer and BASF to battle over Monsanto?
    | Thu, May 12, 3:37 PM | 7 Comments
  • Wed, Mar. 2, 12:49 PM
    • Monsanto (MON -7.5%) sinks after cutting its FY 2016 and Q2 profit outlook, citing weak foreign currencies, increased generic competition and compressed grower margins.
    • CEO Hugh Grant says MON may not achieve its target of doubling EPS by 2019 because of the current struggles, and that MON is no longer interested in buying Syngenta (SYT -0.9%) after the latter agreed to be acquired by ChemChina.
    • Before MON's announcement, the Bernstein research firm called a bottom in the agricultural cycle, which it sees as positive for MON and Potash (POT +3.4%), as spot potash prices are expected to trend positively during the spring planting season.
    • Related tickers: DD -1.2%, DOW -0.8%, AGU -1.2%, CF -3.5%.
    | Wed, Mar. 2, 12:49 PM | 9 Comments
  • Tue, Feb. 2, 9:17 AM
    | Tue, Feb. 2, 9:17 AM | 5 Comments
  • Fri, Jan. 15, 2:13 PM
    • Syngenta (SYT +1.7%) is one of today's few gainers amid today's stock market carnage, as Bloomberg reports the company's board has thrown its support behind a potential deal with ChemChina.
    • SYT’s board met this week and voted in favor of pursuing advanced takeover talks, which could pave the way for a formal agreement to be reached by the Chinese New Year holiday in early February, according to the report.
    • Speculation has mounted that SYT would seek a deal following last month’s merger agreement between Dow Chemical and DuPont, which will create the world’s largest agriculture business.
    | Fri, Jan. 15, 2:13 PM
  • Wed, Jan. 6, 2:19 PM
    • Monsanto (MON -1.8%) CEO Hugh Grant says a deepening decline in the agricultural industry has strengthened the rationale for combining the company, the world’s largest seller of seeds, with Syngenta (SYT -2.2%), the top seller of pesticides, but engagement about a possible merger has been “difficult."
    • In today's earnings conference call, Grant did not elaborate on the difficulty in engaging SYT, but said MON still sees a "significant opportunity" through integrating SYT's pesticide portfolio and that MON's pipeline of crop genes, high-performing seeds and new computer-powered farming services make the company a prime partner for merger deals.
    • SYT CFO and interim CEO John Ramsay had said in an interview last month that the company was discussing possible deals with “a number of parties” and signaled new openness to discussing a deal with MON.
    • Earlier: Monsanto to cut more jobs as Q4 sales slide, 2016 EPS outlook trimmed
    | Wed, Jan. 6, 2:19 PM | 2 Comments
  • Dec. 22, 2015, 2:57 PM
    • Syngenta (SYT +4.1%) is in talks with Monsanto (MON +2.1%), ChemChina and others but has not received a concrete takeover offer and is keeping all options open, Chairman Michel Demare says.
    • SYT's board, which this year rebuffed a takeover offer from MON, is considering making an acquisition, merging with a rival or selling the company, according to Demare.
    • "Given what shareholders expect for the next 12 months, going it alone is hardly possible," Demare says, explaining that SYT could move ahead on its own but shareholders currently lack the patience to wait for a cyclical upswing; sector consolidation also is adding pressure to act, he says.
    • Earlier: Syngenta upgraded to Buy from Hold at Jefferies, as warm weather a boost
    • Earlier: Syngenta open to deals with rivals including Monsanto, CEO says (Dec. 18)
    | Dec. 22, 2015, 2:57 PM | 1 Comment
  • Dec. 22, 2015, 10:11 AM
    • Syngenta (SYT +1.5%) is upgraded to Buy from Hold with an $88 price target, raised from $66, at Jefferies, which cites the unusually warm winter in the U.S. as a positive for both insecticide and fungicide demand, and a wetter than usual spell in southern Brazil also should support fungicide demand.
    • SYT is in "not that bad a slump," Jefferies says, as EPS arguably has troughed while matching the prior cyclical peak, which it considers a resilient performance compared with ag equipment suppliers.
    • The firm also views recent buyer talk favorably and sees a greater than 75% chance of a deal happening.
    | Dec. 22, 2015, 10:11 AM | 3 Comments
  • Dec. 21, 2015, 5:37 PM
    • Top gainers, as of 5.25 p.m.: AMID +2.8%. SYT +2.0%. MDCO +2.0%. XIV +1.9%. SNY +1.8%.
    • Top losers, as of 5.25p.m.: SCS -20.0%. TVIX -4.0%. VIIX -2.2%. TS -2.2%. BP -1.9%.
    | Dec. 21, 2015, 5:37 PM | 5 Comments
  • Dec. 18, 2015, 5:41 PM
    • Top gainers, as of 5.25 p.m.: SYT +4.4%. FCAU +3.3%. CEN +2.4%. AAP +2.3%. RIO +2.2%.
    • Top losers, as of 5.25p.m.: SBSA -4.9%. AG -3.8%. CBD -2.8%. FTR -1.3%. IMGN -1.1%.
    | Dec. 18, 2015, 5:41 PM
  • Dec. 18, 2015, 5:41 PM
    • Syngenta (NYSE:SYT+6.8% AH after Bloomberg reports that ChemChina has improved its offer to buy the company, proposing a complex two-stage takeover that would mark the biggest-ever acquisition by a Chinese company.
    • ChemChina reportedly is offering to buy 70% of SYT now, with an option to acquire the remaining 30% later, and is said to be offering ~470 Swiss francs/share for the first 70%, an improvement over its previous cash offer of 449 francs/share that was deemed too low.
    • Earlier: Syngenta open to deals with rivals including Monsanto, CEO says
    | Dec. 18, 2015, 5:41 PM | 2 Comments
  • Dec. 18, 2015, 12:17 PM
    • Interim Syngenta (SYT +2.1%) CEO John Ramsay tells Dow Jones the company is discussing possible deals with "a number of parties" and is open to combinations with companies including Monsanto (MON +0.9%).
    • While Ramsay says MON has not revived its $46B takeover effort that was abandoned in August, his comment that SYT is "interested in any value-adding opportunity that exists for us in this industry, which includes Monsanto and many others" marks a notable departure from its earlier stand.
    • Last week's merger between DuPont (DD -0.7%) and Dow Chemical (DOW -0.4%) removed two potential partners for SYT and eventually could pose a greater competitive threat in the ~$100B global seed and pesticide industry.
    | Dec. 18, 2015, 12:17 PM | 1 Comment
  • Dec. 9, 2015, 12:10 PM
    • Any merger between Dow Chemical (DOW +10.5%) and DuPont (DD +12.6%) would have far-reaching consequences for European rivals, prompting a series of moves as pesticide and seed makers scramble to face a combined U.S. giant.
    • A merger would make it more likely that Monsanto (MON +0.2%) re-approaches Syngenta (SYT +7.7%), Bernstein analysts say, speculating that a new bid could come in at 485 Swiss francs, more than the 470 cash-and-stock offer withdrawn in August.
    • The pressure on MON to defend its position as the biggest seeds player would be "huge" as chemical companies will want to defend or even strengthen their market positions, says MM Warburg's Oliver Schwarz.
    • Regulatory hurdles to a merger would require the combined company to sell off some businesses, likely sparking interest from contenders such as BASF (OTCQX:BASFY -0.1%), Schwarz says. “All the big companies that are swimming in this pond would probably be interested in taking over assets that Dow or DuPont would sell."
    | Dec. 9, 2015, 12:10 PM | 7 Comments
  • Nov. 18, 2015, 2:23 PM
    • Syngenta (SYT -3.7%) and other major players in the seeds and crop chemicals industry are in active discussions about potential tie-ups, Financial Times cites Chairman Michel Demare as saying in an interview.
    • Conversations among the leading companies in the sector were "extremely active... "We are all convinced that [the sector] will look quite different in six months," Demare says.
    • The comments come after Monsanto (MON +1.4%), which withdrew a bid to take over SYT earlier this year, said yesterday it was discussing whether to acquire or merge with major rivals in the seed and agrochemical industries.
    | Nov. 18, 2015, 2:23 PM | 2 Comments
  • Nov. 17, 2015, 2:32 PM
    • Monsanto (MON -0.8%) top execs are discussing whether it should try to acquire agrochemical rivals, including another potential run at Syngenta (SYT +6.8%), MON President Brett Begemann says.
    • The internal discussions, ongoing since MON abandoned its $46B offer for SYT in August, include weighing the benefits of bidding for rivals such as Bayer CropScience (OTCPK:BAYRY +1.1%), Reuters reports.
    • MON expects its profit growth will reach 20%/year, and says it does not need a big acquisition to achieve its previously reported goal of doubling earnings to more than $10/share by 2019, Begemann also says.
    • Earlier: Syngenta pops on news of another Monsanto approach
    | Nov. 17, 2015, 2:32 PM | 2 Comments
  • Nov. 17, 2015, 11:27 AM
    | Nov. 17, 2015, 11:27 AM
Company Description
Syngenta AG is engaged in the manufacture, development, and distribution of crop protection products and seeds. It operates through the following geographical segments: Europe, Africa and Middle East; North America; Latin America; Asia Pacific; and Lawn and Garden. The four geographic regions... More
Industry: Agricultural Chemicals
Country: Switzerland